Quick Answer
Fortress Biotech, Inc. reported Operating Income of -$70.22 million for fiscal year 2025.
Fortress Biotech, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$70.22M | +36.4% |
| 2024 | -$110.38M | +22.5% |
| 2023 | -$142.34M | +30.1% |
| 2022 | -$203.56M | -8.0% |
| 2021 | -$188.54M | -100.0% |
| 2020 | -$94.27M | +14.9% |
| 2019 | -$110.82M | +7.6% |
| 2018 | -$120.00M | -33.6% |
| 2017 | -$89.80M | -36.7% |
| 2016 | -$65.71M | -30.0% |
| 2015 | -$50.53M | -144.7% |
| 2014 | -$20.65M | +42.3% |
| 2013 | -$35.78M | -31.7% |
| 2012 | -$27.18M | +22.5% |
| 2011 | -$35.04M | -279.2% |
| 2010 | -$9.24M | -253.7% |
| 2009 | -$2.61M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.81M | +69.2% | +81.3% |
| June 30, 2025 | -$36.47M | -31.3% | -63.4% |
| March 31, 2025 | -$22.32M | +39.0% | -1.0% |
| September 30, 2024 | -$22.09M | -60.6% | +20.5% |
| June 30, 2024 | -$27.79M | +44.5% | +24.0% |
| March 31, 2024 | -$36.57M | +37.9% | -165.8% |
| September 30, 2023 | -$13.76M | +72.9% | +72.5% |
| June 30, 2023 | -$50.10M | +1.6% | +14.9% |
- Fortress Biotech, Inc. showed an increase of +36.4% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, Fortress Biotech, Inc.’s operating income has declined by 2587.4% (from -$2.61 million to -$70.22 million).
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: